Partner Therapeutics' Leukine® (sargramostim) Receives Approval in Japan to Treat Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
Treatment will be Marketed by Nobelpharma Co. Ltd. Under the Trade Name Sargmalin®
Source: eagletribune.com
Stay updated with breaking news from Project Professor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Treatment will be Marketed by Nobelpharma Co. Ltd. Under the Trade Name Sargmalin®
/PRNewswire/ -- Partner Therapeutics, Inc. (PTx) announced that its partner Nobelpharma received approval from the Japanese Pharmaceuticals and Medical Device...
/PRNewswire/ -- Voyager Space (Voyager), a global leader in space exploration, today announced Dr. Soichi Noguchi has been appointed to the company's advisory...
Former JAXA Astronaut Dr. Soichi Noguchi Joins Voyager Space Advisory Board
[Translation] To Our Shareholders: June 5, 2024 ...